Bioprovar Corporation

Houston, TX Doing business as Bioprovar

UEI
J39NNLDS4KJ7
CAGE
70LH0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
8027 Oakington Dr, Houston, TX 77071, USA
Website
bioprovar.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Bioprovar Corporation's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
An innovative immune therapy targeting the TREM1-inflammation pathway to alleviate excess inflammation in ulcerative… Grant · R43AG087800 National Institute on Aging $620,725
An innovative immune therapy with antibiotics to treat deadly excess inflammation in sepsis and ards induced from severe… Grant · U44AG074105 National Institute on Aging $2,446,568

Quick answers

What is Bioprovar Corporation's UEI?

Bioprovar Corporation's Unique Entity ID (UEI) in SAM.gov is J39NNLDS4KJ7.

What is Bioprovar Corporation's CAGE code?

Bioprovar Corporation's CAGE code is 70LH0.

What is Bioprovar Corporation's primary NAICS code?

Bioprovar Corporation's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Bioprovar Corporation located?

Bioprovar Corporation's physical address in SAM.gov is 8027 Oakington Dr, Houston, TX 77071, USA.

Is Bioprovar Corporation registered in SAM.gov?

Yes. Bioprovar Corporation's SAM.gov registration is active through October 2, 2027.

What is Bioprovar Corporation's most recent federal award?

Bioprovar Corporation's most recent federal grant award is An innovative immune therapy targeting the TREM1-inflammation pathway to alleviate excess inflammation in ulcerative… (R43AG087800), from National Institute on Aging, on September 25, 2024.

On GovTribe

See Bioprovar Corporation's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login